Biohaven (BHVN) is up 6.1%, or $2.17 to $37.95.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BHVN:
- 3 Best Stocks to Buy Now, 12/17/2024, According to Top Analysts
- Biohaven reports clinical, regulatory milestones across MoDE platform
- Biohaven to present expanded safety data from BHV-7000 multiple-dose studies
- Biohaven price target raised to $61 from $58 at RBC Capital
- Scholar Rock price target raised to $45 from $36 at Truist